Retour
Fourchette du Jour
4,87 €
5,39 €
Fourchette 52 Semaines
1,33 €
6,88 €
Volume
1 733 268
Moyenne 50J / 200J
5,90 €
/
4,29 €
Clôture Précédente
5,04 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,1 | 0,4 |
| P/B | 3,8 | 2,9 |
| ROE % | -41,3 | 3,9 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
11,00 €
+106.4%
Low: 9,00 €
High: 15,00 €
BPA Prévisionnel
-0,40 €
CA Est.
1,3 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,17 €
-0,25 € – 4,04 €
|
650 M | 12 |
| FY2029 |
0,51 €
-0,11 € – 1,75 €
|
400 M | 8 |
| FY2028 |
-0,06 €
-1,73 € – 0,85 €
|
190 M | 14 |
Points Clés
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -49,17M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-41,29%
ROIC-26,44%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,05
Current Ratio15,02
Interest Coverage0,00
Valorisation
P/E Ratio
-11,09
P/B Ratio3,75
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -66,49M |
| ROE | -41,29% | ROA | -30,28% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -49,17M |
| ROIC | -26,44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 15,02 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,09 | P/B Ratio | 3,75 |
| P/S Ratio | N/A | PEG Ratio | -0,76 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 737,07M | Enterprise Value | 716,25M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 850 000,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -66,49M | -49,38M | -42,49M | -39,23M | -82,18M |
| EPS (Diluted) | -0,42 | -0,36 | -0,33 | -0,35 | -1,31 |
| Gross Profit | 0,0 | 850 000,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -72,84M | -56,63M | -50,36M | -41,66M | -81,88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 219,59M | 140,40M | 156,88M | 199,65M | 153,76M |
| Total Liabilities | 22,80M | 15,17M | 8,34M | 18,01M | 13,68M |
| Shareholders' Equity | 196,79M | 125,23M | 148,54M | 181,64M | 140,08M |
| Total Debt | 9,83M | 6,63M | 1,73M | 2,94M | 4,04M |
| Cash & Equivalents | 30,64M | 43,48M | 24,23M | 34,95M | 144,51M |
| Current Assets | 209,82M | 132,75M | 153,88M | 194,79M | 147,11M |
| Current Liabilities | 13,97M | 8,87M | 7,80M | 16,17M | 10,63M |